P&G Health Limited reported a mixed set of financial numbers for the third quarter, reflecting strong topline growth but pressure on profitability due to margin contraction.
For Q3, the company posted a net profit of ₹77.6 crore, marking a year-on-year decline of 14.7% compared with ₹91 crore reported in the same quarter last year. The drop in profit came despite healthy revenue growth, indicating rising costs and operating pressures during the period.
Revenue from operations surged 20.7% YoY to ₹374 crore, up from ₹309.8 crore in the corresponding quarter of the previous year. The robust revenue performance was driven by steady demand across key product categories and improved market traction.
However, EBITDA declined 10.5% YoY to ₹110.6 crore versus ₹123.6 crore a year ago. As a result, EBITDA margin stood at 29.6% in Q3, significantly lower than 39.9% recorded in the same period last year. The sharp margin contraction suggests higher input costs, increased spending, or changes in product mix impacting operating profitability.
